BMO Capital analyst Evan Seigerman raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $545 from $520 and keeps an Outperform ...
In the most recent trading session, Nice (NICE) closed at $165, indicating a -0.6% shift from the previous trading day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback